Pecam Is An Effective And Safe Anthracycline-Containing Third-Line Regimen For Patients With Relapsed Or Refractory Non-Hodgkin Lymphoma

Fumi Nakamura,Honoka Arai,Katsuya Tokita,Shiho Furuichi, Fusako Sugita-Nagasawa,Wataru Takahashi,Tomoyuki Handa,Hisako Iso,Jiro Tadokoro,Shigeharu Tsurumi,Yuko Nakamura,Yuka Nakamura,Ko Sasaki,Sachiko Seo,Motoshi Ichikawa,Kinuko Mitani

LEUKEMIA & LYMPHOMA（2021）

引用 0|浏览34

暂无评分

摘要

Despite the progress in the treatment of previously untreated patients with diffuse large B-cell lymphoma (DLBCL) [1,2], 24% of patients relapse within 10 years of achieving complete response (CR) ...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要